期刊
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
卷 46, 期 4, 页码 190-197出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejps.2011.06.006
关键词
Systems biology; Emergence; Silicon human; Network targeting drugs; Nuclear receptors
资金
- STW
- NGI-kluyver Centre
- NWO-SysMo
- BBSRC-MCISB
- SysMO
- SysMO2
- ERASysBio
- BRIC
- EPSRC
- AstraZeneca
- EU
- ESF
- FEBS
- Biotechnology and Biological Sciences Research Council [BB/C008219/1] Funding Source: researchfish
The development of disease may be characterized as a pathological shift of homeostasis; the main goal of contemporary drug treatment is, therefore, to return the pathological homeostasis back to the normal physiological range. From the view point of systems biology, homeostasis emerges from the interactions within the network of biomolecules (e.g. DNA, mRNA, proteins), and, hence, understanding how drugs impact upon the entire network should improve their efficacy at returning the network (body) to physiological homeostasis. Large, mechanism-based computer models, such as the anticipated human whole body models (silicon or virtual human), may help in the development of such network-targeting drugs. Using the philosophical concept of weak and strong emergence, we shall here take a more general look at the paradigm of network-targeting drugs, and propose our approaches to scale the strength of strong emergence. We apply these approaches to several biological examples and demonstrate their utility to reveal principles of bio-modeling. We discuss this in the perspective of building the silicon human. Crown Copyright (C) 2011 Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据